Participant characteristics
| Patient ID . | Age at MPN diagnosis (y) . | Sex . | Diagnosis . | WBC count (×106/L) . | Hb (g/L) . | Platelet count (×106/L) . | Time between samples (y) . |
|---|---|---|---|---|---|---|---|
| P1 | 53.6 | F | PV | 17.3 | 194 | 550 | 10.1 |
| P2 | 24.2 | F | PV | n/a | n/a | n/a | 5.5 |
| P3 | 53.4 | F | MF | 4.2 | 112 | 130 | 12.6 |
| P4 | 24.5 | M | ET | 8.4 | 15.6 | 600 | 4.6 |
| P5 | 58.7 | F | ET | 8.94 | 142 | 637 | 14.5 |
| P6 | 40.6 | F | PV | 7.7 | 168 | 602 | 6.8 |
| P7 | 68.2 | M | MF | 8.1 | 81 | 74 | 15.2 |
| P8 | 33 | M | ET | 10.3 | 149 | 776 | 12.1 |
| P9 | 43.2 | M | ET | 12.1 | 148 | 793 | 9.4 |
| P10 | 66.9 | F | PV | 7.6 | 154 | 830 | 14.7 |
| P11 | 58.4 | M | PV | 12.7 | 220 | 423 | 10.3 |
| P12 | 27 | F | ET | 5.1 | 135 | 750 | 4.6 |
| Patient ID . | Age at MPN diagnosis (y) . | Sex . | Diagnosis . | WBC count (×106/L) . | Hb (g/L) . | Platelet count (×106/L) . | Time between samples (y) . |
|---|---|---|---|---|---|---|---|
| P1 | 53.6 | F | PV | 17.3 | 194 | 550 | 10.1 |
| P2 | 24.2 | F | PV | n/a | n/a | n/a | 5.5 |
| P3 | 53.4 | F | MF | 4.2 | 112 | 130 | 12.6 |
| P4 | 24.5 | M | ET | 8.4 | 15.6 | 600 | 4.6 |
| P5 | 58.7 | F | ET | 8.94 | 142 | 637 | 14.5 |
| P6 | 40.6 | F | PV | 7.7 | 168 | 602 | 6.8 |
| P7 | 68.2 | M | MF | 8.1 | 81 | 74 | 15.2 |
| P8 | 33 | M | ET | 10.3 | 149 | 776 | 12.1 |
| P9 | 43.2 | M | ET | 12.1 | 148 | 793 | 9.4 |
| P10 | 66.9 | F | PV | 7.6 | 154 | 830 | 14.7 |
| P11 | 58.4 | M | PV | 12.7 | 220 | 423 | 10.3 |
| P12 | 27 | F | ET | 5.1 | 135 | 750 | 4.6 |
F, female; Hb, hemoglobin concentration; M, male; MF, idiopathic myelofibrosis; n/a, not available; WBC, white blood cell.